ALTME.PA
Price:
$0.1074
Market Cap:
$10.12M
TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a str...[Read more]
Industry
Biotechnology
IPO Date
2016-09-30
Stock Exchange
PAR
Ticker
ALTME.PA
According to TME Pharma N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.51. This represents a change of -24.62% compared to the average of -0.68 of the last 4 quarters.
The mean historical PE Ratio of TME Pharma N.V. over the last ten years is -1.90. The current -0.51 PE Ratio has changed 2.59% with respect to the historical average. Over the past ten years (40 quarters), ALTME.PA's PE Ratio was at its highest in in the December 2019 quarter at 2.26. The PE Ratio was at its lowest in in the June 2017 quarter at -3.74.
Average
-1.90
Median
-1.41
Minimum
-7.54
Maximum
-0.09
Discovering the peaks and valleys of TME Pharma N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.89%
Maximum Annual PE Ratio = -0.09
Minimum Annual Increase = -91.12%
Minimum Annual PE Ratio = -7.54
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.87 | 423.09% |
| 2024 | -0.36 | 108.07% |
| 2023 | -0.17 | 80.93% |
| 2022 | -0.09 | -91.12% |
| 2021 | -1.07 | -38.86% |
| 2020 | -1.75 | -76.82% |
| 2019 | -7.54 | 1.89% |
| 2018 | -0.38 | -84.66% |
| 2017 | -2.46 | -24.82% |
| 2016 | -3.28 | 125.25% |
The current PE Ratio of TME Pharma N.V. (ALTME.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.80
5-year avg
-0.71
10-year avg
-1.90
TME Pharma N.V.’s PE Ratio is less than Mauna Kea Technologies S.A. (7.71), greater than AMA Corporation Plc (-1.07), less than Plant Advanced Technologies S.A. (8.47), greater than Bluelinea S.A. (-1.71), less than Media Lab S.p.A. (38.21), greater than Valbiotis S.A. (-1.64), less than Biophytis S.A. (-0.03), greater than SpineGuard S.A. (-4.41), less than Biosynex S.A. (-0.22), less than Poxel S.A. (-0.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| 7.71 | $30.58M | |
| -1.07 | $8.57M | |
| 8.47 | $4.92M | |
| -1.71 | $3.13M | |
| 38.21 | $5.88M | |
| -1.64 | $28.61M | |
| -0.03 | $1.55M | |
| -4.41 | $10.08M | |
| -0.22 | $17.55M | |
| -0.49 | $9.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TME Pharma N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TME Pharma N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TME Pharma N.V.'s PE Ratio?
How is the PE Ratio calculated for TME Pharma N.V. (ALTME.PA)?
What is the highest PE Ratio for TME Pharma N.V. (ALTME.PA)?
What is the 3-year average PE Ratio for TME Pharma N.V. (ALTME.PA)?
What is the 5-year average PE Ratio for TME Pharma N.V. (ALTME.PA)?
How does the current PE Ratio for TME Pharma N.V. (ALTME.PA) compare to its historical average?